About SeeMedX
Press Releases
Find the latest announcements, news, and breakthroughs from SeeMedX. Our technology will be a valued tool in resuscitations, cardiac care, and critical care.
LAS VEGAS, June 18, 2024 | PRNewswire | SeeMedX, Inc. ("SeeMedX") today announced the appointment of Dr. Peter Ganz to its advisory board, effective immediately. Dr. Ganz is a distinguished leader in cardiology and a pioneer in clinical cardiac research, including current work with precision medicine enabled by proteomics and machine learning.
LAS VEGAS, November 4, 2024 | PRNewswire | SeeMedX Inc. ("SeeMedX") today announced the submission of its 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its innovative, non-invasive cardiac monitoring device, designed to allow medical professionals to have real-time insights into cardiac performance and fluid status. SeeMedX's technology enables clinicians to make informed decisions, optimizing heart failure treatment with greater speed and safety than current options.